Wolfram Pönisch Selected Research

Bendamustine Hydrochloride

8/2021	Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV).
1/2021	Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network.
12/2017	Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).
10/2017	Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV).
3/2015	Changes in the diagnosis and treatment of patients with low grade lymphoma in Germany: years 2006-2009.
11/2014	Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma.
11/2013	Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure.
7/2013	Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077.
3/2013	Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma.
1/2013	[Therapeutic strategies in multiple myeloma: the future role of bendamustine].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wolfram Pönisch Research Topics

Disease

14	Multiple Myeloma 08/2021 - 08/2002
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021 - 02/2002
4	Renal Insufficiency (Renal Failure) 11/2013 - 08/2002
3	Leukemia 02/2019 - 11/2005
2	Thrombocytopenia (Thrombopenia) 01/2021 - 03/2013
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2019 - 01/2019
2	Neoplasms (Cancer) 12/2019 - 03/2010
2	Pathologic Complete Response 01/2019 - 04/2017
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2022
1	Myalgia 01/2021
1	Disease Susceptibility (Diathesis) 01/2021
1	Chills 01/2021
1	Hyperferritinemia 01/2021
1	Nausea 01/2021
1	Pain (Aches) 01/2020
1	Wilms Tumor (Wilm's Tumor) 02/2019
1	Residual Neoplasm 04/2017
1	Gonorrhea 01/2017
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2015
1	Lymphoma (Lymphomas) 03/2015
1	Neutropenia 03/2013
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2010
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2008
1	Hematologic Diseases (Blood Diseases) 02/2003
1	Hypercalcemia (Milk Alkali Syndrome) 08/2002
1	Anemia 08/2002

Drug/Important Bio-Agent (IBA)

13	Bendamustine Hydrochloride FDA Link 08/2021 - 08/2002
6	Bortezomib (Velcade)FDA Link 08/2021 - 08/2012
6	Prednisone (Sone)FDA LinkGeneric 08/2021 - 08/2012
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 06/2012
3	Lenalidomide (CC 5013)FDA Link 12/2017 - 06/2012
3	Prednisolone (Predate)FDA LinkGeneric 12/2017 - 10/2008
2	Thalidomide (Thalomid)FDA Link 01/2020 - 10/2008
2	Proteasome InhibitorsIBA 11/2014 - 03/2013
2	CreatinineIBA 11/2013 - 06/2012
1	EnzymesIBA 01/2021
1	carfilzomibIBA 01/2021
1	AntioxidantsIBA 01/2021
1	Thioctic Acid (Lipoic Acid)IBA 01/2021
1	ixazomibIBA 01/2020
1	NucleophosminIBA 02/2019
1	Biological ProductsIBA 04/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Rituximab (Mabthera)FDA Link 03/2015
1	Cytostatic AgentsIBA 03/2013
1	Hemoglobins (Hemoglobin)IBA 01/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2003
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2003
1	fludarabineIBA 02/2003
1	ParaproteinsIBA 08/2002
1	Proteins (Proteins, Gene)FDA Link 08/2002
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2002

Therapy/Procedure

10	Therapeutics 11/2021 - 02/2002
7	Stem Cell Transplantation 10/2020 - 10/2008
5	Hematopoietic Stem Cell Transplantation 11/2021 - 10/2017
4	Homologous Transplantation 01/2019 - 03/2015
3	Drug Therapy (Chemotherapy) 04/2017 - 08/2002
3	Cell Transplantation 01/2008 - 02/2003
1	Hematopoietic Stem Cell Mobilization 01/2022
1	Transplantation 03/2010
1	Maintenance Chemotherapy 11/2005